Get the Stockscreener App
187.02
1.44%
2.0953
Overview
News
Price History
Option Chain
Financials
Why ORCL Down?
Discussions
Forecast
Stock Split
Dividend History
Oracle Corp stock is traded at $187.02, with a volume of 10.07M.
It is up +1.44% in the last 24 hours and down -15.83% over the past month.
Oracle provides enterprise applications and infrastructure offerings through a variety of flexible IT deployment models, including on-premises, cloud-based, and hybrid. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system, which is commonly used by the world's largest companies for high-volume online transaction processing workloads. Besides databases, Oracle also sells enterprise resource planning platforms and cloud infrastructure that play an increasingly important role in large language model training and inferencing.
See More
Previous Close:
$184.92
Open:
$184.7
24h Volume:
10.07M
Relative Volume:
0.39
Market Cap:
$536.79B
Revenue:
$61.02B
Net Income/Loss:
$15.61B
P/E Ratio:
35.15
EPS:
5.3211
Net Cash Flow:
$-13.18B
1W Performance:
-15.33%
1M Performance:
-15.83%
6M Performance:
-11.14%
1Y Performance:
+9.55%
1-Day Range:
$184.49
$189.60
1-Week Range:
$181.40
$225.32
52-Week Range:
$118.86
$345.72
Oracle Corp Stock (ORCL) Company Profile
Name
Oracle Corp
Sector
Industry
Phone
(737) 867-1000
Address
2300 ORACLE WAY, AUSTIN, CA
Compare ORCL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ORCL
Oracle Corp
|
186.83 | 531.30B | 61.02B | 15.61B | -13.18B | 5.3211 |
|
MSFT
Microsoft Corporation
|
474.08 | 3.53T | 293.81B | 104.91B | 78.02B | 14.06 |
|
PLTR
Palantir Technologies Inc
|
183.61 | 436.76B | 3.90B | 1.10B | 1.79B | 0.4275 |
|
CRWD
Crowdstrike Holdings Inc
|
483.33 | 122.89B | 4.57B | -315.36M | 1.10B | -1.2634 |
|
SNPS
Synopsys Inc
|
458.25 | 86.65B | 7.05B | 1.34B | 1.35B | 8.0204 |
Oracle Corp Stock (ORCL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-11-25 | Reiterated | BMO Capital Markets | Outperform |
| Dec-03-25 | Initiated | Wells Fargo | Overweight |
| Nov-10-25 | Downgrade | Erste Group | Buy → Hold |
| Oct-13-25 | Reiterated | BMO Capital Markets | Outperform |
| Oct-09-25 | Initiated | Robert W. Baird | Outperform |
| Sep-25-25 | Initiated | Rothschild & Co Redburn | Sell |
| Sep-10-25 | Reiterated | BMO Capital Markets | Outperform |
| Sep-10-25 | Upgrade | BofA Securities | Neutral → Buy |
| Sep-10-25 | Upgrade | Citigroup | Neutral → Buy |
| Sep-09-25 | Reiterated | BMO Capital Markets | Outperform |
| Jul-17-25 | Initiated | Scotiabank | Sector Outperform |
| Jul-10-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jul-02-25 | Reiterated | BMO Capital Markets | Outperform |
| Jun-30-25 | Upgrade | Stifel | Hold → Buy |
| Jun-18-25 | Reiterated | Guggenheim | Buy |
| Jun-13-25 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Jun-09-25 | Reiterated | BMO Capital Markets | Market Perform |
| Apr-23-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Mar-19-25 | Initiated | Stephens | Equal-Weight |
| Mar-11-25 | Reiterated | BMO Capital Markets | Market Perform |
| Mar-03-25 | Upgrade | Monness Crespi & Hardt | Sell → Neutral |
| Jan-17-25 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-20-24 | Downgrade | Monness Crespi & Hardt | Neutral → Sell |
| Oct-23-24 | Initiated | RBC Capital Mkts | Sector Perform |
| Sep-16-24 | Upgrade | Melius | Hold → Buy |
| Sep-10-24 | Reiterated | BMO Capital Markets | Market Perform |
| Sep-10-24 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Jun-17-24 | Reiterated | BMO Capital Markets | Market Perform |
| Apr-18-24 | Initiated | Oppenheimer | Perform |
| Mar-21-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Mar-14-24 | Upgrade | Argus | Hold → Buy |
| Mar-12-24 | Reiterated | BMO Capital Markets | Market Perform |
| Mar-12-24 | Upgrade | William Blair | Mkt Perform → Outperform |
| Dec-12-23 | Reiterated | BMO Capital Markets | Market Perform |
| Nov-13-23 | Upgrade | Edward Jones | Hold → Buy |
| Oct-09-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-15-23 | Initiated | HSBC Securities | Buy |
| Sep-14-23 | Upgrade | DZ Bank | Hold → Buy |
| Sep-13-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-12-23 | Downgrade | Monness Crespi & Hardt | Buy → Neutral |
| Sep-05-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-29-23 | Upgrade | UBS | Neutral → Buy |
| Jun-13-23 | Upgrade | Goldman | Sell → Neutral |
| Jun-12-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Apr-20-23 | Reiterated | KeyBanc Capital Markets | Overweight |
| Mar-10-23 | Downgrade | Societe Generale | Buy → Hold |
| Jan-18-23 | Initiated | DA Davidson | Neutral |
| Jan-11-23 | Initiated | Mizuho | Buy |
| Jan-09-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-05-23 | Upgrade | Jefferies | Hold → Buy |
| Oct-21-22 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Oct-20-22 | Upgrade | Piper Sandler | Underweight → Neutral |
| Sep-14-22 | Initiated | Berenberg | Hold |
| Aug-12-22 | Initiated | Guggenheim | Buy |
| Jun-29-22 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Jun-27-22 | Resumed | Goldman | Sell |
| Jun-14-22 | Reiterated | Monness Crespi & Hardt | Buy |
| Apr-01-22 | Initiated | Daiwa Securities | Neutral |
| Mar-29-22 | Downgrade | Exane BNP Paribas | Neutral → Underperform |
| Mar-11-22 | Downgrade | Piper Sandler | Neutral → Underweight |
| Mar-11-22 | Upgrade | Societe Generale | Hold → Buy |
| Dec-21-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Dec-15-21 | Upgrade | DZ Bank | Sell → Hold |
| Dec-10-21 | Reiterated | BMO Capital Markets | Market Perform |
| Dec-10-21 | Reiterated | Barclays | Equal Weight |
| Dec-10-21 | Reiterated | Citigroup | Neutral |
| Dec-10-21 | Reiterated | Cowen | Outperform |
| Dec-10-21 | Upgrade | Deutsche Bank | Hold → Buy |
| Dec-10-21 | Reiterated | Monness Crespi & Hardt | Buy |
| Dec-10-21 | Reiterated | Piper Sandler | Neutral |
| Dec-10-21 | Reiterated | Societe Generale | Hold |
| Dec-10-21 | Reiterated | Stifel | Hold |
| Dec-10-21 | Reiterated | UBS | Neutral |
| Dec-10-21 | Reiterated | Wolfe Research | Peer Perform |
| Nov-16-21 | Initiated | Credit Suisse | Outperform |
| Nov-02-21 | Initiated | Deutsche Bank | Hold |
| Sep-14-21 | Reiterated | BMO Capital Markets | Market Perform |
| Sep-14-21 | Reiterated | Monness Crespi & Hardt | Buy |
| Aug-10-21 | Downgrade | DZ Bank | Hold → Sell |
| May-10-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Apr-23-21 | Initiated | Wolfe Research | Peer Perform |
| Apr-21-21 | Downgrade | DZ Bank | Buy → Hold |
| Apr-01-21 | Resumed | Wedbush | Neutral |
| Mar-22-21 | Resumed | Evercore ISI | In-line |
| Mar-16-21 | Resumed | Credit Suisse | Outperform |
| Mar-11-21 | Reiterated | Monness Crespi & Hardt | Buy |
| Mar-11-21 | Downgrade | Societe Generale | Buy → Hold |
| Mar-05-21 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-03-21 | Resumed | Citigroup | Neutral |
| Jan-22-21 | Initiated | Goldman | Sell |
| Dec-18-20 | Upgrade | Monness Crespi & Hardt | Neutral → Buy |
| Dec-16-20 | Resumed | BofA Securities | Neutral |
| Dec-08-20 | Downgrade | Cleveland Research | Buy → Neutral |
| Nov-24-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-14-20 | Resumed | UBS | Neutral |
| Sep-21-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Sep-11-20 | Reiterated | BMO Capital Markets | Market Perform |
| Sep-11-20 | Reiterated | Barclays | Equal Weight |
| Sep-11-20 | Reiterated | Credit Suisse | Outperform |
| Sep-11-20 | Reiterated | Goldman | Buy |
| Sep-11-20 | Reiterated | Jefferies | Hold |
| Sep-11-20 | Reiterated | Morgan Stanley | Equal-Weight |
| Sep-11-20 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-11-20 | Reiterated | Stifel | Hold |
| Sep-11-20 | Reiterated | Wells Fargo | Overweight |
| Jun-19-20 | Downgrade | Argus | Buy → Hold |
| Jun-01-20 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Mar-31-20 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Mar-20-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-13-20 | Reiterated | BMO Capital Markets | Market Perform |
View All
Oracle Corp Stock (ORCL) Latest News
CoreWeave, Oracle Stocks Plunge As Generative AI Bubble Deflates - Forbes
Oracle Stock Offers Underwater Bulls a Potential Reprieve - Investing.com
Oracle (ORCL): New Buy Recommendation for This Technology Giant - The Globe and Mail
Jackson Wealth Management LLC Raises Stake in Oracle Corporation $ORCL - MarketBeat
Shorepoint Capital Partners LLC Buys New Position in Oracle Corporation $ORCL - MarketBeat
Texas Permanent School Fund Corp Has $25.20 Million Stake in Oracle Corporation $ORCL - MarketBeat
Oracle Corporation $ORCL is Neville Rodie & Shaw Inc.'s 5th Largest Position - MarketBeat
Larry Ellison Calls the Shots in Oracle’s AI Bet - Bloomberg.com
Oracle Shares Drop After Forecast Falls Short and AI Spending Surges - Yahoo Finance
GAMMA Investing LLC Has $11.05 Million Stock Position in Oracle Corporation $ORCL - MarketBeat
Oracle’s $248 Billion Rent is Another AI ‘Bombshell’ - Bloomberg.com
Energy Transfer Stock Is Below $17. Time to Buy? - The Motley Fool
Goldman Sachs slashes PT on Oracle Corporation (ORCL) to $220 from $320 - MSN
Goldman Sachs Slashes PT on Oracle Corporation (ORCL) to $220 From $320 - Finviz
Wall Street Maintains its Mixed Outlook on Oracle (ORCL) - Yahoo Finance UK
Down 42% From Its High, Is Oracle the Best AI Growth Stock to Buy in 2026? - Nasdaq
Buy the Drop in Broadcom or Oracle Stock After Earnings? - Yahoo Finance
After selling stake in Ampere, Oracle fields more Arm cores - theregister.com
Oracle a ‘Show Me Story’ on Big AI Debt Bet, JPMorgan Says - Yahoo Finance
Oracle: I Mistimed The Top, Now I Am Buying The Bottom (ORCL) - Seeking Alpha
Oracle Secures $150B in Q2 Data Center Leases Amid AI Surge - WebProNews
Oracle: OpenAI Is A Huge Wildcard (NYSE:ORCL) - Seeking Alpha
Healthcare Organizations Enhance Efficiency with Oracle Fusion Cloud Applications - PR Newswire
Oracle is getting hammered over AI spending. It’s time for a second look. - MSN
Oracle Is Getting Hammered Over AI Spending. It’s Time for a Second Look. - Barron's
Should You Buy the Dip in Oracle Stock and Hold for 2026? - Yahoo Finance
Oracle Launches A4 Instances with AmpereOne Arm Processors for AI Gains - WebProNews
Oracle still a great company, stock just got ahead of itself: Ariel Investments' Charles Bobrinskoy - MSN
Delays? What delays? Oracle insists its $300B cloud contract with OpenAI is on track - theregister.com
Oracle Stock Can't Shake Slide As AI Data Center Stocks Fall - Investor's Business Daily
Oracle: Let It Fall, Let It Fall, Let It Fall (NYSE:ORCL) - Seeking Alpha
Introducing OCI Ampere A4 Standard: Next-Generation Arm-Based Cloud Compute for Performance and Efficiency - Oracle Blogs
Oracle Keeps Growing Cloud Footprint With Ampere After Stake Sale - CRN Magazine
Why Oracle’s stock — and its bonds — can’t shake off AI spending fears - MarketWatch
Oracle Crushes Q2 Financial Metric that Matters Most: RPO - Cloud Wars
Tesla and Oracle among market cap stock movers on Monday - Investing.com
Oracle keeps Outperform rating at Mizuho with $400 target - Yahoo Finance
Oracle Stock Today (ORCL): AI Capex, OpenAI Data Center Questions, and Multicloud Expansion Fuel Fresh Volatility on Dec. 15, 2025 - ts2.tech
5 Things To Watch Amid Underwhelming Oracle Quarter, Massive AI Buildout - CRN Magazine
Oracle: Overdone Fears Around OpenAI, Stock Remains A Strong Buy (NYSE:ORCL) - Seeking Alpha
523 Billion Reasons to Buy Oracle Stock in December - Yahoo Finance
Oracle says it might let customers bring their own hardware into its data centers - Data Center Dynamics
Valeo Financial Advisors LLC Purchases 4,512 Shares of Oracle Corporation $ORCL - MarketBeat
Oracle Stock (ORCL) News Today (Dec. 15, 2025): $50B AI Capex Shock, OpenAI Data Center Questions, and Wall Street Forecasts - ts2.tech
Oracle shares have plunged. Should investors buy the dip heading into 2026? - MSN
Here Are Monday’s Top Wall Street Analyst Research Calls: Bristol-Myers Squibb, GE Vernova, KLA Corp., Klaviyo, Las Vegas Sands, ServiceNow, and More - 24/7 Wall St.
Oracle denies OpenAI data center delays - Data Center Dynamics
3,405 Shares in Oracle Corporation $ORCL Acquired by Milestones Private Investment Advisors LLC - MarketBeat
Silicon Valley Capital Partners Has $16.21 Million Position in Oracle Corporation $ORCL - MarketBeat
Mizuho maintains Oracle stock rating at Outperform with $400 target - Investing.com
Oracle Shares Have Plunged. Should Investors Buy the Dip Heading Into 2026? - Yahoo Finance
Oracle Corp Stock (ORCL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.33%
0.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):